About SwitchGear Genomics
SwitchGear Genomics is a company based in Menlo Park (United States) founded in 2006 was acquired by Active Motif in March 2013. SwitchGear Genomics operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Active Motif
(Mar 21, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SwitchGear Genomics
Detailed funding history for SwitchGear Genomics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in SwitchGear Genomics
SwitchGear Genomics has secured backing from 1 investor. Prominent investors backing the company include Active Motif.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Epigenetics and gene regulation research tools are developed and distributed.
|
Locked | Locked | Locked |
Investor details for SwitchGear Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SwitchGear Genomics
Investment portfolio details for SwitchGear Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SwitchGear Genomics
Detailed financials for SwitchGear Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Switchgear Genomics Comparisons
Peer comparison for SwitchGear Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SwitchGear Genomics
SwitchGear Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of SwitchGear Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Switchgear Genomics
Complete news archive for SwitchGear Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SwitchGear Genomics
SwitchGear Genomics was founded in 2006.
SwitchGear Genomics is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
SwitchGear Genomics was founded in 2006 in Menlo Park, United States, within the biotechnology sector focused on functional genomics. Functional elements in the human genome are identified, and genomic content is transformed into high-throughput cell-based assays. Products such as reporter constructs, promoter controls, synthetic response elements, miRNA mimics, and enhancer vectors are provided for applications including miRNA target validation, gene regulation studies, transcription factor analysis, and screening processes.
SwitchGear Genomics's top competitors include Novogene Corporation, BGI and Source BioScience.
SwitchGear Genomics has 1 investor. Key investors include Active Motif.